Search Results

Alternate Access Approaches for Self-Expanding TAVR Devices

Developing transcatheter aortic valve replacement technology will allow treatment for a broader spectrum of patient anatomies.

By Nicolas M. Van Mieghem, MD; Carl Schultz, MD, PhD; Hafid Amrane, MD; and Peter P. de Jaegere, MD, PhD

Aortic Valve Update

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

TAVR Using CoreValve

World experience and an update of the United States pivotal trial.

By Peter S. Fail, MD, FACC, FACP; Edgar Feinberg, MD, FACS; and Gary Chaisson, RTR, RICA

TAVI Using the CoreValve Revalving System

An update on device data and the latest trial findings.

By Jeffery J. Popma, MD; Roger Laham, MD; Robert Hagberg, MD; and Kamal Khabbaz, MD

Post-PCI Selection of Antithrombotic Therapy

Improvements in antithrombotic pharmacotherapy have led to important reductions in complications after percutaneous coronary intervention.

By John P. Vavalle, MD, and Robert A. Harrington, MD

Stent Thrombosis in BMS and DES

More issues than answers.

By Mitchell W. Krucoff, MD, FACC

CoreValve: Assessing the Clinical Trials

A review of trial patient selection and results, as well as clinical implications.

By Steven J. Yakubov, MD, FACC, and Kyle Feldmann, MD